Skip to main content
. 2019 Dec 13;4(2):pkz101. doi: 10.1093/jncics/pkz101

Table 2.

Statin use in entire lung adenocarcinoma cohort

Variable No. (%)
Statin use
 No statin 538 (56.2)
 Statin 282 (29.4)
 Unknown 138 (14.4)
Statin type
 Atorvastatin 77 (27.3)
 Simvastatin 177 (62.8)
 Other 28 (9.9)
Statin dose
 <40 mg 152 (53.9)
 ≥40 mg 130 (46.1)
Statin duration
 <1 mo 94 (33.3)
 1–6 mo 85 (30.1)
 >6 mo 101 (35.8)
 Unknown 2 (0.7)